The future of AML and MDS diagnosis and treatment
Stéphane de Botton
Checkpoint inhibitors in Hodgkin lymphoma
Immunotherapy and its dependence on T-cells
Tackling unmet needs in lymphoma
CAR T-cells in myeloma: are they as promising as we think?